A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy
Abstract Background Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This stu...
Saved in:
Main Authors: | Kate Williams (Author), Ian Davidson (Author), Mark Rance (Author), Katharina Buesch (Author), Sarah Acaster (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model
by: Kate Williams, et al.
Published: (2021) -
Correction of human nonsense mutation via adenine base editing for Duchenne muscular dystrophy treatment in mouse
by: Ming Jin, et al.
Published: (2024) -
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy
by: Jennifer E. Hibma, et al.
Published: (2023) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021)